Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × telisotuzumab vedotin × Clear all

Phase

Status

Sponsor Class

INDUSTRY 8 OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Recurrent Squamous Cell Lung Carcinoma 1

Interventions

Radiotherapy 255 Cisplatin 236 Cyclophosphamide 191 Doxorubicin 146 Paclitaxel 145 Carboplatin 134 Vincristine 130 Etoposide 117 Filgrastim 113 Fluorouracil 101 Gemcitabine 100 Docetaxel 97 Dexamethasone 88 Methotrexate 86 Cytarabine 85 Leucovorin 77 Prednisone 74 Gene Expression Profiling 72 Granulocyte Colony-Stimulating Factor 60 Capecitabine 53 Irinotecan 50 Specimen Handling 46 Radiation 46 Oxaliplatin 46 Ifosfamide 46 Magnetic Resonance Spectroscopy 45 Polymerase Chain Reaction 44 Radiotherapy, Conformal 42 Platinum 42 Immunohistochemistry 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03574753 2021-10-18

Lung-MAP S1400K: c-MET Positive

SWOG Cancer Research Network

Phase 2 Completed

28 enrolled 18 charts

Recurrent Squamous Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡